Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Laura DONI"'
Autor:
Francesco Bloise, Fiorella Manfredi, Luca Zatteri, Giovanni Dima, Chiara Carli, Rosanna Di Vita, Maria Olivieri, Enrico Sammarco, Marco Ferrari, Alessia Salfi, Adele Bonato, Debora Serafin, Natalia Coccia, Laura Doni, Luca Galli, Michele Sisani, Giandomenico Roviello, Martina Catalano, Federico Paolieri
Publikováno v:
Cells, Vol 13, Iss 11, p 961 (2024)
The treatment landscape for metastatic renal cell carcinoma (mRCC) has undergone significant transformations in recent years. The introduction of novel combination therapies involving tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors
Externí odkaz:
https://doaj.org/article/b38241af5f1b4f76bba025d2dca14af1
Autor:
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Giuseppe Fornarini, Sara Elena Rebuzzi, Umberto Basso, Davide Bimbatti, Laura Doni, Gabriella Nesi, Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, Luca Galli, Andrea Sbrana, Raffaele Conca, Claudia Carella, Emanuele Naglieri, Sandro Pignata, Giuseppe Procopio, Lorenzo Antonuzzo
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3084-3092 (2022)
Abstract Background Nivolumab and cabozantinib are currently approved agents in metastatic renal cell carcinoma (mRCC) but there are no data available for patients progressing to both treatments. The aim of this study was to compare active therapeuti
Externí odkaz:
https://doaj.org/article/5c1b0d246d484bad81a6a45b350d5ccd
Autor:
Agnese Paderi, Sara Fancelli, Enrico Caliman, Serena Pillozzi, Elisabetta Gambale, Marinella Micol Mela, Laura Doni, Francesca Mazzoni, Lorenzo Antonuzzo
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3259-3267 (2021)
Background: Immunotherapy has completely changed the treatment of solid tumors. Although immune checkpoint inhibitors (ICIs) seem to be an appealing alternative to chemotherapy, especially in elderly patients, due to a more tolerable toxicity profile
Externí odkaz:
https://doaj.org/article/5376654c34084a43a3836b59703bcd3b
Autor:
Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Sebastiano Buti, Elisabetta Gambale, Giuseppe Procopio, Carlotta Ottanelli, Enrico Caliman, Luca Isella, Pierangela Sepe, Nicole Brighi, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAlthough serum sodium concentration, particularly hyponatremia, has been shown to be a prognostic marker of survival in metastatic renal cell carcinoma (mRCC), the impact of normal sodium levels has not been investigated. Herein, we investi
Externí odkaz:
https://doaj.org/article/c05b7b7444424caf8d07cb9291a2892b
Autor:
Lorenzo Antonuzzo, Sara Fancelli, Maria Cristina Petrella, Elisabetta Gambale, Enrico Caliman, Laura Doni, Serena Pillozzi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Cemiplimab is a highly potent, hinge-stabilized human IgG4 monoclonal antibody (mAb) targeting programmed cell death 1 (PD-1) receptor approved for patients with locally advanced or metastatic cutaneous squamous cell carcinoma (SCC) who are not candi
Externí odkaz:
https://doaj.org/article/d79d2fe829e3406b813e2a61ea366086
Autor:
Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Davide Bimbatti, Sebastiano Buti, Giulia Mazzaschi, Giuseppe Procopio, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo, Giandomenico Roviello
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2444 (2022)
Background: Tyrosine kinase inhibitors (TKIs) prolong progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC), some of which may achieve long-term responses. Herein, we report clinical and pathological characteristics
Externí odkaz:
https://doaj.org/article/9e5a1738975b4a3a81c625d59f9b2c30
Autor:
Vincenzo De Giorgi, Luciana Trane, Giulia Pieretti, Nicola Santoro, Flavia Silvestri, Federico Venturi, Federica Scarfi, Vincenza Maio, Giuseppe Spinelli, Silvia Scoccianti, Laura Guerrini, Daniela Massi, Cinzia Mazzini, Laura Doni
Publikováno v:
Dermatology Reports (2021)
Background: The management of difficult-to-treat periocular basal cell carcinoma becomes very challenging in cases of delayed diagnosis, leading to the development of locally advanced basal cell carcinoma. Objective: The aim of this study was to eval
Externí odkaz:
https://doaj.org/article/0c83f705cbc047ea918d0401cfa430c5
Autor:
Lucrezia Becattini, Calogero Saieva, Laura Doni, Giandomenico Roviello, Pietro Spatafora, Martina Catalano, Francesco Sessa, Ilaria Camilla Galli, Claudio Bisegna, Francesco Lupo Conte, Claudia Zaccaro, Raffaella Santi, Sergio Serni, Gabriella Nesi, Donata Villari
Publikováno v:
Medicina, Vol 58, Iss 7, p 886 (2022)
Background and Objectives: The incidence of urothelial cancer in males is higher than in females; however, females have a higher risk of recurrence and progression. The aim of our study was to report the effect of gender on the oncological outcome in
Externí odkaz:
https://doaj.org/article/e944cfc56eb847fd841efdd3279a38db
Autor:
Rodolfo Passalacqua, Silvia Lazzarelli, Maddalena Donini, Rodolfo Montironi, Rosa Tambaro, Ugo De Giorgi, Sandro Pignata, Raffaella Palumbo, Giovanni Luca Ceresoli, Gianluca Del Conte, Giuseppe Tonini, Franco Morelli, Franco Nolè, Stefano Panni, Ermanno Rondini, Annalisa Guida, Paolo Andrea Zucali, Laura Doni, Elisa Iezzi, Caterina Caminiti
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Vinflunine is the only chemotherapeutic agent shown to improve survival in platinum-refractory patients with metastatic transitional cell carcinoma of the urothelium (TCCU) in a phase III clinical trial, which led to product regis
Externí odkaz:
https://doaj.org/article/908c9733b96a4d20a13b5e2fbf50b4a0
Autor:
Rossana Berardi, Candida Mastroianni, Giuseppe Lo Russo, Roberta Buosi, Daniele Santini, Agnese Montanino, Carlo Carnaghi, Marcello Tiseo, Rita Chiari, Andrea Camerini, Sandro Barni, Valeria De Marino, Daris Ferrari, Antonella Cristofano, Laura Doni, Federica Freddari, Daniele Fumagalli, Luigi Portalone, Roberta Sarmiento, Giovanni Schinzari, Francesca Sperandi, Marcello Tucci, Alessandro Inno, Libero Ciuffreda, Marita Mariotti, Cinzia Mariani, Miriam Caramanti, Mariangela Torniai, Rosaria Gallucci, Chiara Bennati, Paola Bordi, Lucio Buffoni, Achille Galeassi, Michele Ghidini, Emidio Grossi, Alessandro Morabito, Bruno Vincenzi, Emanuela Arvat
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Hyponatremia in cancer patients is often caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The aim of this observational multicenter study was to analyze the medical and economic implications of SIADH in this
Externí odkaz:
https://doaj.org/article/35962965fe4b448a9213dbbff50072dc